ARTICLE | Company News
ExonHit, bioMerieux cancer diagnostics deal
December 6, 2001 8:00 AM UTC
ExonHit (Paris, France) and bioMerieux- Pierre Fabre (Marcy l'Etoile, France) entered a 5-year deal to develop ExonHit's Proof-Hit cancer diagnostic for breast and colon cancer. ExonHit's differential...